Eckert Taori Jacobson Hensgens Ty

105 MONDAY SCIENTIFIC SESSIONS Final Program K-924 Successful Treatment of Simulated Clostridium difficile Infec- tion in a Human Gut Model by Fidaxomycin After Vancomycin or Metronidazole Failure C. H. Chilton 1 , G. Crowther 1 , J. Freeman 1 , S. Todhunter 1 , S. Nicholson 1 , C. Longshaw 2 , M. H. Wilcox 1 ; 1 Univ. of Leeds Leeds Teaching Hosp., Leeds, United Kingdom, 2 Astellas Phama Europe Ltd, Staines, United Kingdom. K-925 Clostridium difficile in Ready-to-Eat Raw Vegetables, France

C. Eckert

1,2 , B. Burghoffer 1,2 , F. Barbut 1,2 ; 1 Natl. Reference Lab. for C. difficile, Saint-Antoine Hosp., AP-HP, Paris, France, 2 UPMC Univ Paris 06, Paris, France. K-926 Procalcitonin Levels Correlate with Severity in Cases of Clostridium difficile Infection K. Rao, S. T. Walk, D. Micic, E. Chenoweth, L. Deng, MA Associate, R. Jain, I. Trivedi, M. Yu , C. Ring, V. B. Young , G. B. Huffnagle, D. M. Aronoff ; Univ. of Michigan, Ann Arbor, MI. K-927 Analysis of Sequential Isolates from Clostridium difficile Infec- tions by MLVA Subtyping

S. Taori

1,2 , A. Wroe 1 , K. Templeton 2 , A. Gibb 2 , I. Poxton 1 ; 1 Univ. of Ed- inburgh, Edinburgh, United Kingdom, 2 NHS Lothian, Edinburgh, United Kingdom. K-928 Evaluation of ATLAS Score in Predicting Clinical Cure and Recurrence of Clostridium difficile Infection CDI

S. Jacobson

1 , D. Slain 2 ; West Virginia Univ., Morgantown, WV. K-929 Do Antibiotic Combinations with Rifampin for Osteoarticular Infections Protect against Clostridium difficile-Associated Colitis? C. Landelle , M. Schindler , W. Zingg , L. Pagani , I. Uckay, D. Pittet; Univ. of Geneva Hosp., Geneva, Switzerland. K-930 Case-Control Study of Community-Onset Clostridium difficile Infections in the Netherlands

M. Hensgens

1 , A. Demeulemeester 2 , O. Dekkers 1 , A. Buiting 3 , P. Bloem- bergen 4 , B. van Benthem 5 , E. Kuijper 1 ; 1 LUMC, Leiden, Netherlands, 2 SHL, Breda, Netherlands, 3 Elisabeth Hosp., Tilburg, Netherlands, 4 Isala, Zwolle, Netherlands, 5 Natl. Inst. for Publ. Hlth. and the Environment, Bilthoven, Netherlands. K-931 Is There Any Correlation Between Microbiological Profile and the Prognosis of Clostridium difficile Disease CDD? D. Rodriguez-Pardo, B. Almirante, R. Bartolomé, J. Vila, B. Mirelis, F. March, T. Cornejo, M. Español, M. Lung, A. Pahissa; Barcelona Clostridium difficile Project Study Group, Barcelona, Spain. K-932 Risk Factors Predictive of Recurrent C. difficile Infection

P. Ty

1 , A. Wong-Beringer 2,1 ; 1 Huntington Hosp., Pasadena, CA, 2 Univ Southern California, Los Angeles, CA. K-933 Study on the Molecular Epidemiology and Antibiotic Resis- tance of Clostridium difficile Isolates in Shijiazhuang of China

J. Zhao